New treatment options
Although implants with SLActive® surface are suitable for all indications, the high treatment-security they provide render them especially beneficial to advanced and complex treatment protocols in challenging indications.
Higher treatment predictability and reduced risks
Compared to SLA®, SLActive® provides 60% more bone-to-implant contact two weeks after insertion, as shown in animal tests. This substantially higher BIC-value results in improved treatment predictability for all protocols and helps to minimize the potential for early implant failures. But also, SLActive® outperform competitive products in the market:
Significantly higher shear strength values for SLActive® than for TiUnite® after 3 and 6 weeks6
Fig. 1: Shear strength (N/mm2) displayed as shear force normalized by surface area after 10 days, 3 weeks and 6 weeks after implant placement.
* p < 0.001 after 3 weeks, p < 0.001 after 6 weeks
TiUnite® is a registered trademark of Nobel Biocare Services AG, Switzerland.
Significantly higher mean new bone height and bone-to-implant contact for SLActive® implants after 2 and 8 weeks when compared to NanoTite®
SLActive® implants may have a higher potential to support osseointegration in dehiscence-type defects than NanoTite® implants7
NanoTite® is a registered trademark of BIOMET 3i, Inc., USA.
* Increased treatment predictability in critical protocols - Based on the following study: Ganeles J et. al. Immediate and early loading of Straumann implants with a chemically modified surface (SLActive®) in the posterior mandible and maxilla: 1-year results from a prospective multicenter study. Clin. Oral Impl. Res 2008;19:1119-1128
6 Gottlow et al. Influences of implant design and surface properties on osseointegration and implant stability. A biomechanical and histological study in the rabbit. The Toronto Osseointegration Conference Revisited., Toronto, ON, Canada. May 8-10, 2008
7 Schwarz et al. Influence of titanium implant surface characteristics on bone regeneration in dehiscence-type defects: an experimental study in dogs. J. Clin. Periodontol. 2010;37(5):466-473
